Cancer pill makeover may mess with treatment adherence
NCT ID NCT07664683
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 334 cancer patients to see if switching between different-looking generic chemo pills affects their adherence and health outcomes. Researchers will track pill counts and patient surveys over six months. The goal is to understand if changes in pill color, shape, or packaging cause confusion or missed doses, and to inform better policies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
oral antineoplastics (chemotherapy pills)
What this could lead to
If successful, this could lead to policies that keep pill appearance consistent, helping cancer patients stay on track with their treatment.
What could go wrong
This is an observational study, not testing a new drug. Results may not apply to all cancer types or settings, and adherence is hard to measure accurately.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universidad Miguel Hernández
RECRUITINGSan Juan, Alicante, 03550, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••